CoChat
Sign Up
Cited by 346Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersNeuroendocrine regulation and behavior

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.

Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis

Open access
Gabriele, Stefano, Sacco, Roberto, Persico, Antonio M.·2014·European Neuropsychopharmacology
DOI 10.1016/j.euroneuro.2014.02.004
Open this paper in CoChat — free account

Abstract

Elevated blood serotonin (5-HT) levels were the first biomarker identified in autism research. Many studies have contrasted blood 5-HT levels in autistic patients and controls, but different measurement protocols, technologies, and biomaterials have been used through the years. We performed a systematic review and meta-analysis to provide an overall estimate of effect size and between-study heterogeneity, while verifying whether and to what extent different methodological approaches influence the strength of this association. Our literature search strategy identified 551 papers, from which 22 studies providing patient and control blood 5-HT values were selected for meta-analysis. Significantly higher 5-HT levels in autistic patients compared to controls were recorded both in whole blood (WB) [O.R.=4.6; (3.1-5.2); P=1.0×10(-12]), and in platelet-rich plasma (PRP) [O.R.=2.6 (1.8-3.9); P=2.7×10(-7)]. Predictably, studies measuring 5-HT levels in platelet-poor plasma (PPP) yielded no significant group difference [O.R.=0.54 (0.2-2-0); P=0.36]. Altogether, elevated 5-HT blood levels were recorded in 28.3% in WB and 22.5% in PRP samples of autistic individuals, as reported in 15 and 4 studies, respectively. Studies employing HPLC vs fluorometric assays yield similar cumulative effect sizes, but the former display much lower variability. In summary, despite some limitations mainly due to small study sample sizes, our results significantly reinforce the reliability of elevated 5-HT blood levels as a biomarker in ASD, providing practical indications potentially useful for its inclusion in multi-marker diagnostic panels for clinical use.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.euroneuro.2014.02.004

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 75 references

Cited by

Sorted by citations

Items 301–346 of 346

Related

See all

Metadata

Authors
Gabriele, S., Sacco, R., & Persico, A. M.
Affiliations
Università Campus Bio-Medico (IT)
Corresponding author
Persico, Antonio M.
ORCID
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
2014-06
Volume
24
Issue
6
Pages
919-929
ISSN
0924-977X (ISSN-L)
DOI
10.1016/j.euroneuro.2014.02.004
OpenAlex
W2158197814
Cited by
346
References
75
Citations by year
2026: 21 · 2025: 18 · 2024: 36 · 2023: 43 · 2022: 31 · 2021: 40 · 2020: 27 · 2019: 30 · 2018: 26 · 2017: 22 · 2016: 17 · 2015: 20 · 2014: 14
FWCI
2.36
Type
journal article
Language
en
Open access
Licence
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords
autism spectrum disorder, blood serotonin, serotonin, biomarkers, platelet-rich plasma, whole blood, platelet-poor plasma, diagnostic panel, methodological heterogeneity
MeSH terms
Blood Chemical Analysis, Child Development Disorders, Pervasive, Humans, Serotonin, Biomarkers, Platelet-Rich Plasma, Endophenotypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review